Immersive Virtual Reality Training for Improving Cognition in Adults With Metabolic Syndrome

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age45-70
SponsorConsorci Sanitari de Terrassa

About this trial

This study aims to evaluate the effectiveness of a multimodal intervention using immersive virtual reality (Virtual-METS) to improve cognitive function in middle-aged adults with metabolic syndrome and subjective cognitive complaints. The intervention combines cognitive training and physical exercise in group sessions over 12 weeks.

Eligibility criteria

Qualifiers

Demonstrated criteria for the MetS: central obesity (waist circumference ≥ 94 cm for men or ≥ 80 cm for women) and at least 2 of the criteria described as follow: Triglycerides ≥ 150 mg/dl or specific treatment of this lipid disorder; HDL-C < 40 mg/dl (men) or < 50 mg/dl (women) or specific treatment of this lipid disorder; Systolic blood pressure ≥ 130 mmHg or diastolic blood pressure ≥ 85 mmHg or previously diagnosed hypertension treatment; Basal glycemia ≥ 100 mg/dl or type 2 diabetes previously diagnosed).

Age: between 45 and 70 years old.

Subjective cognitive complaints: Subjective Cognitive Decline Questionnaire (≥ 7).

Ability to fully understand and speak Spanish or Catalan.

Disqualifiers

Confirmed or suspicion of dementia (MMSE<24).

Diagnosis of severe psychiatric, neurological, developmental disorders, systemic pathologies, hematological, hormonal, nutritional pathology, and/or neoplasm that are known to cause cognitive deficits.

Other severe comorbidities considered a probable bias for the study: a cardiac history of unstable angina, recent myocardial infarction within the last 3 months, congestive heart failure, significant heart valve dysfunction, or unstable hypertension; taking medications that could negatively affect cognitive function.

Physical, motor, or sensory alterations that impede the neuropsychological examination or the rehabilitation program.

Trial design

Treatments tested in this trial

  • Immersive VR-Based Multimodal Intervention (Virtual-METS)

Treatment groups

84 Participants
are divided into 2 treatment groups

Sponsors and collaborators